Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Exemestane

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 5,616Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Marksans Pharma's UK Arm, Relonchem, Secures MHRA Approval
    Marksans Pharma's UK Arm, Relonchem, Secures MHRA Approval

    06 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/marksans-pharmas-uk-arm-relonchem-secures-mhra-nod-for-exemestane-25mg-tablets-18159

    INDPHARMAPOST
    06 Nov 2025
    Share Share
    Qilu Pharm`s Generic Exemestane Receives Approval in US
    Qilu Pharm`s Generic Exemestane Receives Approval in US

    16 Apr 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213547

    FDA
    16 Apr 2020
    Share Share
    Mayne Pharma’s Generic Exemestane Receives Approval In US
    Mayne Pharma’s Generic Exemestane Receives Approval In US

    13 Aug 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208764

    FDA
    13 Aug 2019
    Share Share
    Amneal Pharms' Generic Exemestane Receives Approval in US
    Amneal Pharms' Generic Exemestane Receives Approval in US

    31 Dec 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206421

    FDA
    31 Dec 2018
    Share Share
    Zydus Pharms USA's Generic Exemestane Receives Approval in US
    Zydus Pharms USA's Generic Exemestane Receives Approval in US

    04 Oct 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202602

    FDA
    04 Oct 2018
    Share Share
    Cipla’s Generic Exemestane Receives Approval In US
    Cipla’s Generic Exemestane Receives Approval In US

    01 May 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210323

    FDA
    01 May 2018
    Share Share